Electromed (ELMD)
(Delayed Data from AMEX)
$15.77 USD
-0.41 (-2.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.95 +0.18 (1.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMCompany Summary
Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.
Company Summary
General Information
Electromed, Inc
500 SIXTH AVENUE NW
NEW PRAGUE, MN 56071
Phone: 952-758-9299
Fax: 866-758-5077
Email: investorrelations@electromed.com
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | June |
Last Reported Quarter | 3/31/2024 |
Earnings Date | 5/7/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | NA |
Current Year EPS Consensus Estimate | NA |
Estimated Long-Term EPS Growth Rate | NA |
Earnings Date | 5/7/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 16.18 |
52 Week High | 17.85 |
52 Week Low | 8.80 |
Beta | 0.43 |
20 Day Moving Average | 26,509.80 |
Target Price Consensus | 0.00 |
4 Week | -2.35 |
12 Week | 52.66 |
YTD | 44.55 |
4 Week | 0.60 |
12 Week | 48.43 |
YTD | 35.19 |
Shares Outstanding (millions) | 8.61 |
Market Capitalization (millions) | 135.70 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | 35.04 |
PEG Ratio | NA |
vs. Previous Year | 72.73% |
vs. Previous Quarter | 850.00% |
vs. Previous Year | 16.71% |
vs. Previous Quarter | 11.08% |
Price/Book | 3.35 |
Price/Cash Flow | 35.73 |
Price / Sales | 2.63 |
3/31/24 | NA |
12/31/23 | 10.32 |
9/30/23 | 8.78 |
3/31/24 | NA |
12/31/23 | 8.76 |
9/30/23 | 7.44 |
3/31/24 | NA |
12/31/23 | 5.97 |
9/30/23 | 6.27 |
3/31/24 | NA |
12/31/23 | 5.25 |
9/30/23 | 5.49 |
3/31/24 | NA |
12/31/23 | 7.62 |
9/30/23 | 6.51 |
3/31/24 | NA |
12/31/23 | 7.62 |
9/30/23 | 6.51 |
3/31/24 | NA |
12/31/23 | 10.32 |
9/30/23 | 8.56 |
3/31/24 | NA |
12/31/23 | 4.70 |
9/30/23 | 4.46 |
3/31/24 | NA |
12/31/23 | 2.87 |
9/30/23 | 3.08 |
3/31/24 | NA |
12/31/23 | 0.00 |
9/30/23 | 0.00 |
3/31/24 | NA |
12/31/23 | 0.00 |
9/30/23 | 0.00 |